Preventive plasmapheresis for rituximab related flare in cryoglobulinemic vasculitis

INTRODUCTION: Rituximab monotherapy represents the main therapeutic option for cryoglobulinemic vasculitis (CV) with severe organ involvement. However, initial worsening of the CV, known as rituximab-associated CV flare (=CV flare), has been described and are associated with high mortality rates. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Fornero, Léa, Kanouni, Tarik, Tudesq, Jean-Jacques, Pochard, Camille, Verot, Pauline, Renier, Wendy, Gabellier, Ludovic, Cartron, Guillaume, Guilpain, Philippe, Herbaux, Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9975310/
https://www.ncbi.nlm.nih.gov/pubmed/36874399
http://dx.doi.org/10.1016/j.jtauto.2023.100194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9975310/
https://www.ncbi.nlm.nih.gov/pubmed/36874399
http://dx.doi.org/10.1016/j.jtauto.2023.100194

Ejemplares similares